-
First ever inhalable gene therapy for cancer gets fast-tracked by FDA
11 Feb 2026 13:21 GMT
… first-of-its-kind inhalable gene therapy for lung cancer that genetically modifies people … been testing the gene therapy in people with advanced lung cancer who have exhausted … is also working on inhalable gene therapies for cystic fibrosis and a …
-
bioAffinity Technologies Appoints Nationally Recognized Pulmonary and Lung Cancer Authorities to its Medical and Scientific Advisory Board
09 Feb 2026 15:39 GMT
… Technologies Chief Medical Officer. “Lung cancer is still the leading cause … focused on using gene therapy and immunotherapy to treat lung cancer and mesothelioma … his advanced diagnostic techniques for lung cancer, thoracic oncology and therapeutic …
-
Krystal Biotech Announces RMAT Designation Granted by FDA to KB707 for the Treatment of Advanced or Metastatic Non-Small Cell Lung Cancer
09 Feb 2026 13:00 GMT
… or metastatic non-small cell lung cancer (NSCLC). “The FDA’s decision … of regenerative medicine therapies, including gene therapies. An investigational regenerative medicine therapy … , is the first-ever redosable gene therapy and the first genetic medicine …
-
EGFR-NSCLC Market to Observe Stunning Growth at a CAGR of 9.6% During the Forecast Period (2025-2034) | DelveInsight
12 Feb 2026 01:04 GMT
… bispecifics, CDAC, and gene-therapy combinations signals a densely … Cell Lung Cancer Market
Non-Small Cell Lung Cancer Market … Lung Cancer Clinical Trial Analysis
Non-small Cell Lung Cancer … Small Cell Lung Cancer Market
Small Cell Lung Cancer Market Insights, …
-
Inhalation: A Smart Strategy and Increasing Potential for Drug Delivery
11 Feb 2026 17:18 GMT
… effective for treating lung tumors with reduced systemic … vaccines, lung cancer therapeutics, and drugs for gene therapy.
The … aerosolized immunotherapeutic for lung cancer: pharmacological profile in … of nucleic acid gene therapies in preclinical drug …
-
AstraZeneca raises guidance on stellar cancer drugs growth
10 Feb 2026 20:45 GMT
… weight loss, as well as gene therapies.
In 2025, highlights of AZ … high-risk non-small cell lung cancer (NSCLC). The company said the …
-
CRISPR Turns Oncogene Amplification Into a Cancer Weakness
10 Feb 2026 10:16 GMT
… models of neuroblastoma, small cell lung cancer and colon cancer, this strategy … models of neuroblastoma, small cell lung cancer and colon cancer. These experiments … a basis for developing precision gene therapies for resistant cancers,” the authors …
-
<![CDATA[FDA Grants Designation to Immunotherapy KB707 for Advanced NSCLC]]>
09 Feb 2026 23:42 GMT
… metastatic non-small cell lung cancer (NSCLC). The designation … regenerative medicine therapies, including gene therapies. To qualify, a … 85% of all lung cancer diagnoses. Although many … immune activation within lung tumors while reducing exposure …
-
<![CDATA[FDA Grants RMAT Designation to HSV-Based Immunotherapy in NSCLC]]>
09 Feb 2026 19:39 GMT
… or metastatic non–small cell lung cancer (NSCLC), according to a press … -12) and IL02. The investigational gene therapy can deliver high doses of … or metastatic non-small cell lung cancer. News release. Krystal Biotech, Inc …
-
Oncology Drugs Market Size Worth US$ 324.6 Bn by 2032 at 5.9% CAGR | Persistence Market Research
09 Feb 2026 06:36 GMT
… Checkpoint Inhibitors.
Cell Therapy and Gene Therapy
Oncolytic Virus Therapy
Immune System … Therapy
By Indication
Breast Cancer
Lung Cancer
Prostate Cancer
Multiple Myeloma
Colorectal …